Synthetic Antimicrobial Peptides. II. Antimicrobial and Hemolytic Activity of Cationic Peptides Containing Cysteine Residues with Free Sulfhydryl Groups

2019 ◽  
Vol 45 (6) ◽  
pp. 833-841
Author(s):  
N. V. Amirkhanov ◽  
N. V. Tikunova ◽  
D. V. Pyshnyi
2021 ◽  
Vol 47 (3) ◽  
pp. 681-690
Author(s):  
N. V. Amirkhanov ◽  
A. V. Bardasheva ◽  
N. V. Tikunova ◽  
D. V. Pyshnyi

Abstract We have studied the antimicrobial and hemolytic activity of synthetic antimicrobial peptides (SAMPs), i.e., Arg9Phe2 (P1-Arg), Lys9Phe2 (P2-Lys), and His9Phe2 (P3-His), which have a “linear” type of amphipathicity and contain the cationic amino acid residues of arginine, lysine, or histidine. In this study, we have used various pathogenic microorganism strains of gram-negative bacteria (Pseudomonas aeruginosa, Escherichia coli, and Salmonella enterica), gram-positive bacteria (Staphylococcus aureus), and the conditionally pathogenic yeast fungus (Candida albicans). It has been shown that the replacement of the arginine residues by lysine or histidine residues in the tested SAMPs significantly degrades their antibacterial properties in the series: P1-Arg > P2-Lys $$ \gg $$P3-His. The cationic analog of SAMP, P1-Arg, has the highest antibacterial activity (MIC50 = 43–76 μM), while peptide P3-His does not exhibit this activity (MIC50 > 100 μM). The P1-Arg and P2-Lys peptides were 6–10 times more active against the opportunistic fungus C. albicans (MIC50 6.7 and 10.9 μM, respectively) and the P3-His peptide has 100-times increased antimycotic activity (MIC50 0.6 μM) compared with their effect on bacterial cells. All of the tested peptides with the linear type of amphipathicity and low hydrophobicity, i.e., P1-Arg, P2-Lys, and P3-His, that contain only two Phe residues regardless of the presence of cationic amino acids (Arg, Lys, or His) exhibit a relatively low hemolytic activity (not more than 4% hemolysis at 1000 μM peptide concentration). Thus, considering the same synthesis efficiency (56–63%) and approximately the same low toxicity of the tested SAMPs with a linear type of amphipathicity, it is recommended to use those that contain the cationic arginine or histidine residues to create antibacterial or antifungal peptide agents, respectively.


2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Ines Greco ◽  
Natalia Molchanova ◽  
Elin Holmedal ◽  
Håvard Jenssen ◽  
Bernard D. Hummel ◽  
...  

Life Sciences ◽  
2021 ◽  
pp. 119647
Author(s):  
Patrícia G. Lima ◽  
Jose T.A. Oliveira ◽  
Jackson L. Amaral ◽  
Cleverson D.T. Freitas ◽  
Pedro F.N. Souza

2021 ◽  
Vol 16 (3) ◽  
pp. 447-451
Author(s):  
Tien Duy Vo ◽  
Christoph Spahn ◽  
Mike Heilemann ◽  
Helge B. Bode

eLife ◽  
2019 ◽  
Vol 8 ◽  
Author(s):  
Mark Austin Hanson ◽  
Anna Dostálová ◽  
Camilla Ceroni ◽  
Mickael Poidevin ◽  
Shu Kondo ◽  
...  

Antimicrobial peptides (AMPs) are host-encoded antibiotics that combat invading microorganisms. These short, cationic peptides have been implicated in many biological processes, primarily involving innate immunity. In vitro studies have shown AMPs kill bacteria and fungi at physiological concentrations, but little validation has been done in vivo. We utilized CRISPR gene editing to delete most known immune-inducible AMPs of Drosophila, namely: 4 Attacins, 2 Diptericins, Drosocin, Drosomycin, Metchnikowin and Defensin. Using individual and multiple knockouts, including flies lacking these ten AMP genes, we characterize the in vivo function of individual and groups of AMPs against diverse bacterial and fungal pathogens. We found that Drosophila AMPs act primarily against Gram-negative bacteria and fungi, contributing either additively or synergistically. We also describe remarkable specificity wherein certain AMPs contribute the bulk of microbicidal activity against specific pathogens, providing functional demonstrations of highly specific AMP-pathogen interactions in an in vivo setting.


2018 ◽  
Vol 26 (6) ◽  
pp. 1189-1196 ◽  
Author(s):  
Tracy A. Stone ◽  
Gregory B. Cole ◽  
Huong Q. Nguyen ◽  
Simon Sharpe ◽  
Charles M. Deber

2020 ◽  
Vol 24 ◽  
pp. 100827
Author(s):  
Gabriel S. Vignoli Muniz ◽  
Lilia I. De la Torre ◽  
Evandro L. Duarte ◽  
Esteban N. Lorenzón ◽  
Eduardo M. Cilli ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document